Key result
Sutureless implantation of the Perceval S aortic valve bioprosthesis via ministernotomy was successfully deployed in all patients, with a 30-day mortality of 1.4%.
Why the study?
Is minimally invasive aortic valve replacement with the sutureless Perceval S bioprosthesis safe and effective in patients with isolated aortic valve stenosis?
Population
72 patients with isolated aortic valve stenosis and mean logistic EuroSCORE of 9.7 ± 6.2%.
Design
Cohort
Follow-up
mean 13 ± 6.7 months
Authors
Loading...
May support ministernotomy sutureless AVR; leaves open randomized confirmation versus conventional approaches.
Cohort (n=72)
Is minimally invasive aortic valve replacement with the sutureless Perceval S bioprosthesis safe and effective in patients with isolated aortic valve stenosis?
Sutureless implantation of the Perceval S bioprosthesis via ministernotomy is a feasible and reproducible alternative for aortic valve replacement, offering reduced cross-clamp times and good short-term hemodynamics.
Santarpino et al. (2013) conducted a cohort in Isolated aortic valve stenosis (n=72). Sutureless implantation using the Perceval S aortic valve bioprosthesis via ministernotomy was evaluated on 30-day mortality. Sutureless implantation of the Perceval S aortic valve bioprosthesis via ministernotomy was successfully deployed in all patients, with a 30-day mortality of 1.4%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: